Skip to content
Peptide Clinical Trials intermediate

## Phase III Trials ### Semaglutide - STEP 1 (NCT03548935)

Value

By Encyclopeptide Editorial | 1 min read
peptide-clinical-trials peptide oligopeptide

Overview

Phase III Trials

Semaglutide - STEP 1 (NCT03548935) is a peptide compound with applications in research and therapeutics. Value

Chemical Identity

PropertyValue
Name## Phase III Trials

Semaglutide - STEP 1 (NCT03548935) |

| Sequence | Field | | Length | 5 amino acids |

| Category | Peptide Clinical Trials |

Structure

Phase III Trials

Semaglutide - STEP 1 (NCT03548935) belongs to the Peptide Clinical Trials class of peptides. Its structure and properties make it suitable for various research and therapeutic applications.

Applications

Phase III Trials

Semaglutide - STEP 1 (NCT03548935) has been studied for its potential applications in:

  • Biomedical research
  • Drug discovery
  • Diagnostic applications
  • Therapeutic development

References

  • Source: peptide-clinical-trials.md
  • Database: Wikipept Peptide Database

Test Your Knowledge

Reinforce what you learned about ## Phase III Trials ### Semaglutide - STEP 1 (NCT03548935) with interactive quizzes on Wikipept.

Take a Quiz on Wikipept